GEHC GE HealthCare Inc. Year-over-year net earnings per share growth for the last 12 months
GE HealthCare maintains its status as an impeccable authority in diagnostics, as evidenced by the quarterly dynamics of net income per share. This leadership is bolstered by the integration of AI into imaging, although inflation and electronics shortages create risks. The value of 39.70 serves as the current parameter value, capturing the final capital efficiency and the impact of fiscal factors on business profitability.
Comprehensive metric breakdowns and analytics for GE HealthCare (GEHC)
- share price and expert price forecast:
- market capitalization data:
- book capitalization indicators:
- business debt structure and liquidity details:
Total Debt to Capital GE HealthCare|GEHC - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital GE HealthCare Technologies Inc.|GEHC - Company Total Debt Obligations|Debts to Book Capitalization GE HealthCare Technologies|GEHC - Company Long-Term Liabilities|Company Short-Term Debts GE HealthCare|Quick Liquidity gehealthcare.com
- earnings and market multiples details:
GEHC - Company Net Income|Future Profit GE HealthCare|GEHC - Company Value to Net Income|Forward P/E Multiple GE HealthCare Technologies Inc.|GEHC - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization GE HealthCare|GEHC - Operating profit before depreciation charges|Net earnings per share for the last 12 months GE HealthCare|GEHC - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth gehealthcare.com|GEHC - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year GE HealthCare
- revenue and sales proceeds data:
Analysis of all company metrics:GE HealthCare Inc. - GEHC
GE HealthCare leadership in diagnostics creates high expectations for return on equity. This indicator captures the rolling rate of change in quarterly earnings per share, eliminating lags between reports. Analyzing relative quarterly EPS dynamics allows for an assessment of how AI technologies and clinic modernization impact profitability. The positive trend confirms the effectiveness of the spin-off. This protects investors from purchasing overvalued assets.
Main competitors
ABT (Abbott Laboratories Inc.) - Year-over-year net earnings per share growth for the last 12 months|Thermo Scientific - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months mt.com|Year-over-year net earnings per share growth for the last 12 months Waters Corporation (WAT)|Year-over-year earnings per share growth for the last twelve months Bio-Techne Corp (TECH)|Year-over-year net earnings per share growth for the last 12 months Bruker BRKR|Quarterly EPS earnings growth AZTA (azenta.com)|Varex (VREX) - Earnings per share growth in annualized terms for the last twelve months|Semler Scientific - Quarterly EPS earnings growth|BFLY (Butterfly Network, Inc.) - Year-over-year earnings per share growth for the last 12 months|MLAB: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Quantum-Si Incorporated|NNOX (Nano-X Imaging Ltd) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Quanterix Corp (QTRX)|Quarterly EPS earnings growth MASS|CV (CapsoVision) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months MaxCyte MXCT|rapidmicrobio.com - Year-over-year earnings per share growth for the last twelve months|SEER: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months HYPR (Hyperfine Corp)|FONR: Quarterly EPS earnings growth|Net earnings per share growth for the trailing year Daxor Corporation DXR|Year-over-year earnings per share growth for the last twelve months Spectral AI Inc.|VIVS - Net earnings per share growth for the trailing year|Year-over-year net earnings per share growth for the last 12 months ACON (Aclarion Inc)|Quarterly EPS earnings growth Akoya Biosciences, Inc. (AKYA)|Quarterly EPS earnings growth THMO (thermogenesis.com)|Year-over-year net earnings per share change for the last twelve months Talis Biomedical (TLIS)|TTOO - Year-over-year earnings per share growth for the last twelve months
